Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 12,635
+608 (5.06%)
Apr 1, 2026, 3:29 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 161.72 billion as of April 1, 2026. Its market cap has increased by 4.31% in one year.
Market Cap
161.72B
Enterprise Value
162.68B
Revenue
15.75B
Ranking
n/a
PE Ratio
90.28
Stock Price
12,635.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 161.72B, an increase of 48,154.37%. That is a compound annual growth rate of 27.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 154.12B | -20.92% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 313.33B |
| Gland Pharma | 284.06B |
| Wockhardt | 193.28B |
| Piramal Pharma | 190.63B |
| Eris Lifesciences | 185.77B |
| NATCO Pharma | 175.29B |
| Alembic Pharmaceuticals | 132.40B |
| Alivus Life Sciences | 120.38B |